Related Experiment Video
Updated: Nov 16, 2025
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Coronavirus disease 2019 management
1Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Purpose Of Review:
Coronavirus disease 2019 (COVID-19) is an acute multisystem disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Investigations are ongoing in the search for effective therapeutics, with clinical approaches evolving based upon such evidence.
Recent Findings:
The antiviral agent, remdesivir, and the immunomodulator, dexamethasone, are the first therapeutics for which there is evidence of efficacy from randomized trials. Subgroup analyses suggest remdesivir is beneficial in hospitalized patients whose severity of illness falls at the lower end of the spectrum, while dexamethasone is more beneficial in hospitalized patients whose severity of illness falls at the higher end of the spectrum. We recommend that inpatients who require supplemental oxygen but are not mechanically ventilated receive both remdesivir and dexamethasone, and inpatients who require mechanical ventilation receive dexamethasone monotherapy. Additional evidence regarding anti-SARS-CoV-2 antibodies, convalescent plasma, and a variety of antiinterleukin therapies is forthcoming.
Summary:
The body of evidence related to COVID-19 therapeutics continues to evolve and, as a result, management is likely to change with time. As new evidence is generated and published, the optimal approach to managing patients with COVID-19 should be reconsidered.
Insights
Remdesivir and dexamethasone are effective COVID-19 treatments. Remdesivir benefits less severe cases, while dexamethasone helps severe cases, guiding optimal therapeutic strategies for coronavirus disease 2019.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Pharmacology
Background:
- Coronavirus disease 2019 (COVID-19) is a severe multisystem illness caused by SARS-CoV-2.
- Effective therapeutic strategies for COVID-19 are crucial for patient management.
- Clinical approaches to COVID-19 treatment are continuously evolving based on emerging evidence.
Purpose of the Study:
- To review current evidence on effective therapeutics for COVID-19.
- To provide guidance on the optimal use of remdesivir and dexamethasone.
- To highlight the evolving landscape of COVID-19 treatment.
Main Methods:
- Review of randomized controlled trials and subgroup analyses for COVID-19 therapeutics.
- Evaluation of evidence for remdesivir and dexamethasone efficacy.
- Synthesis of findings to inform clinical recommendations.
Main Results:
- Remdesivir and dexamethasone are the first COVID-19 therapeutics with evidence of efficacy from randomized trials.
- Remdesivir shows benefit in hospitalized patients with less severe illness.
- Dexamethasone is more beneficial in hospitalized patients with severe illness.
Conclusions:
- Hospitalized patients requiring supplemental oxygen but not mechanical ventilation should receive both remdesivir and dexamethasone.
- Hospitalized patients requiring mechanical ventilation should receive dexamethasone monotherapy.
- Ongoing research into other therapies like anti-SARS-CoV-2 antibodies and anti-interleukin agents is critical.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:26Acute Coronary Syndrome V: Nursing Management
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:24Cystic Fibrosis: Management
Sinus disease and chronic...